Literature DB >> 3873387

The immunologic diagnosis of chronic active "autoimmune" hepatitis: distinction from systemic lupus erythematosus.

L E Gurian, T M Rogoff, A J Ware, R E Jordan, B Combes, J N Gilliam.   

Abstract

We have evaluated the immunologic characteristics often associated with systemic lupus erythematosus in a series of patients with a variety of different liver diseases. Antibody to double-stranded DNA as measured by the Farr assay was detected frequently in patients with various forms of liver disease. No patient with liver disease, including those with a presumed immunologic etiology, was found to have antibody to double-stranded DNA using more specific assays. Other immunologic phenomena such as the presence of immunofluorescent staining at the dermal-epidermal junction in the lupus band test, circulating immune complexes and the presence of antinuclear antibody were present in a number of patients with different forms of liver disease. The absence of antibody to double-stranded DNA in patients with liver disease suggests that there may be a true immunologic distinction between systemic lupus erythematosus and chronic active ("lupoid") hepatitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873387     DOI: 10.1002/hep.1840050309

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  Autoimmune hepatitis with raised alpha-fetoprotein level as the presenting symptoms of systemic lupus erythematosus: a case report.

Authors:  Feng-Cheng Liu; Deh-Ming Chang; Jenn-Huang Lai; Chih-Kung Lin; Hsiang-Cheng Chen; Tsung-Yun Hou; San-Yuan Kuo
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

2.  Late-onset systemic lupus erythematosus-associated liver disease.

Authors:  Leonardo L Schiavon; Roberto J Carvalho-Filho; Janaína Luz Narciso-Schiavon; Valéria P Lanzoni; Maria Lucia G Ferraz; Antonio Eduardo B Silva
Journal:  Rheumatol Int       Date:  2010-04-08       Impact factor: 2.631

3.  Liver abnormalities and liver membrane autoantibodies in systemic lupus erythematosus.

Authors:  K Kushimoto; K Nagasawa; A Ueda; T Mayumi; Y Ishii; Y Yamauchi; Y Tada; H Tsukamoto; T Kusaba; Y Niho
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

4.  Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection.

Authors:  F Cassani; L Muratori; P Manotti; M Lenzi; M Fusconi; G Ballardini; L Selleri; U Volta; D Zauli; R Miniero
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

5.  Autoimmune hepatitis or hepatic involvement in SLE?--A case report.

Authors:  Y Moriwaki; A Maebo; W Yamade; T Yamamoto; Y Amuro; T Hada; K Higashino
Journal:  Gastroenterol Jpn       Date:  1987-04

6.  Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis.

Authors:  M W Fried; J O Draguesku; M Shindo; L H Simpson; S M Banks; J H Hoofnagle; A M Di Bisceglie
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

7.  Autoimmune chronic active hepatitis developing after acute type B hepatitis.

Authors:  T Laskus; J Slusarczyk
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

8.  Detection of anti-double and anti-single stranded DNA antibodies in chronic liver disease: significance of anti-double stranded DNA antibody in autoimmune hepatitis.

Authors:  K Tsuchiya; K Kiyosawa; H Imai; T Sodeyama; S Furuta
Journal:  J Gastroenterol       Date:  1994-04       Impact factor: 7.527

9.  Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.

Authors:  D H Van Thiel; H Wright; P Carroll; K Abu-Elmagd; H Rodriguez-Rilo; J McMichael; W Irish; T E Starzl
Journal:  Am J Gastroenterol       Date:  1995-05       Impact factor: 10.864

Review 10.  Epidemiology and treatment of autoimmune hepatitis.

Authors:  Sven Francque; Luisa Vonghia; Albert Ramon; Peter Michielsen
Journal:  Hepat Med       Date:  2012-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.